Gentian Diagnostics
Be the first to follow this company
Gentian Diagnostics is a medical diagnostics company that develops and manufactures in vitro diagnostic reagents for high-throughput analysers. Gentian’s expertise and focus lies within homogenous immunoassays, specifically infections, inflammations, kidney failures and congestive heart failures. The company headquarters and production facilities are located in Moss, Norway, serving the global human and veterinary diagnostics markets through sales and representative offices in key countries.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
Oslo Børs
GENT
Daily low / high price
-
Market cap
-
Turnover
-
Volume
-
Financial calendar
Interim report
29.08.2024
Interim report
31.10.2024
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Vatne Equity AS | 13.7 % | 13.7 % |
Kvantia AS | 10.5 % | 10.5 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
GENT: Groundbreaking assay development for measuring total NT-proBNP levels
Gentian Diagnostics: NT-proBNP successful completion of optimisation phase
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools